Wisekey International Holding S.A.

WSKEF | $0.16 0

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-97.43% volume)
Earnings Calendar:
Market Cap: $ 29,941,284
http://www.wisekey.com
Sec Filling | Patents | n/a employees

(CH) WISeKey International Holding Ltd. is a cybersecurity company, which engages in the provision of digital security technology in the field of cybersecurity, digital identification and authentication of people & objects. It operates through the Internet of Things (IoT) and Managed Public Key (mPKI) segment. The IoT segment encompasses the design, manufacturing, sales and distribution of microprocessors operations. The mPKI segment includes all operations relating to the provision of secured access keys, authentication, signing software, certificates and digital security applications. The company was founded by Carlos Moreira in December 2015 and is headquartered in Zug, Switzerland.

security

add to watch list Paper trade email alert is off

Quotient Ltd

QTNTQ | $0.039 2.56% 8.4K

n/a

(0.0% 1d) (0.0% 1m) (18.9% 1y) (-13.3% 2d) (-17.0% 3d) (0.0% 7d) (53.88% volume)
Earnings Calendar: 2023-02-08
Market Cap: $ 157,366
https://www.quotientbd.com
Sec Filling | Patents | 435 employees

(CH) Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient's proprietary multiplex microarray technology, offers the world's first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. In response to the global effort to combat COVID-19, Quotient developed the MosaiQ COVID-19 Antibody Microarray which is CE marked and has received the U.S. FDA Emergency Use Authorization. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania.

diagnostics games covid

add to watch list Paper trade email alert is off

ABB LTD

ABBNY | News | $48.5 4.05% 200K

n/a

(0.0% 1d) (5.6% 1m) (33.6% 1y) (0.0% 2d) (0.8% 3d) (-0.5% 7d) (-4.72% volume)
Earnings Calendar:
Market Cap: $ 91,277,124,888
https://new.abb.com/
Sec Filling | Patents | 105000 employees

(CH) abb is a global leader in power and automation technologies, providing a broad range of products and solutions to improve performance and reduce environmental impact for its customers. the abb group was formed in 1988 through a merger between asea ab and bbc brown boveri ag. their shares are now listed on the swiss stock exchange, stockholm stock exchange and the new york stock exchange. the consolidated financial statements are made in accordance with united states generally accepted accounting principles (u.s. gaap). the company creates revenues globally in 100 countries with around 140,000 employees, with the corporate headquarters located in zurich.

education

add to watch list Paper trade email alert is off

Energy Holdings, Inc.

MOCI | $0.016 -12.85% 2K

n/a

(0.0% 1d) (17.6% 1m) (-73.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-25.0% volume)
Earnings Calendar:
Market Cap: $ 5,214,864

Sec Filling | Patents | n/a employees

(CH)

add to watch list Paper trade email alert is off

Relief Therapeutics Holding SA

RLFTY | $1.4006 733.33% 100

n/a

(0.0% 1d) (-10.0% 1m) (-65.0% 1y) (0.0% 2d) (0.0% 3d) (-2.1% 7d) (-75.0% volume)
Earnings Calendar:
Market Cap: $ 19,665,596
https://relieftherapeutics.com/c
Sec Filling | Patents | 3367 employees

(CH) aeris was founded with the aim of becoming a benchmark on the wind blade manufacturing and, to achieve this goal, has created a highly skilled team with the potential to add value and quality to the product and management and respond efficiently to the challenges of the market.

add to watch list Paper trade email alert is off

Relief Therapeutics Holding SA

RLFTF | $1.45 11.45% 1.3K

n/a

(0.0% 1d) (-11.6% 1m) (7612.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (130.4% volume)
Earnings Calendar:
Market Cap: $ 20,359,214
http://www.relieftherapeutics.com
Sec Filling | Patents | n/a employees

(CH) RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology company. It engages in the development and licensing of its portfolio of medicinal products candidates. Its products include aviptadil, for respiratory indications such as sarcoidosis and pulmonary hypertension; and atexakin alfa, for the treatment of diabetic neuropathy. The company was founded in June 2016 and is headquartered in Geneva, Switzerland.

treatment respiratory diabetes diabetic

add to watch list Paper trade email alert is off